Now much work needs to be done by laboratories throughout the world to understand this ancient dialect. We all have big dreams and hopes about the miracles encrypted in these 80,000 compact disks of As, Ts, Cs and Gs. However we cannot enter this revolution with blind aspirations. We must take precautions against the misuse of such rapidly evolving technology. We need to create a balance between profits, fads and ethics.
Molecular biotechnology is undeniably where the money is, both in academia and industry.
To a large extent, money is what has fueled the high-speed train of discoveries since 1953. Yet it could also have terrifying results if the sole motivation is monetary gain. Insurance companies may drop the coverage of clients whom they discover have the genetic propensity toward developing particular conditions. Likewise, businesses might base employment decisions on such genetic predispositions. As genetic engineering will inevitably take on a more predominant role in developing treatments and cures for diseases, we must be cautious when utilizing such techniques.